Implementation of a Pediatric-to-adult Asthma Transition Program

Not Applicable

Completed

• Conditions: Education; Asthma
• Interventions: Other: Asthma Transition Program

• Registration Number: NCT01521247
• Lead Sponsor: University of Calgary

Brief Summary

Despite the clear and often stated need, a formal transition program does not exist for asthma patients as they move from pediatric to adult care in Western Canada. This population is not having their health care needs met. The investigators proposed study would evaluate a well structured transition program designed to facilitate continuity of care for this at risk patient population.

Primary hypothesis: A pediatric-to-adult asthma transition program will improve the asthma-specific quality of life of young asthma patients in the Calgary area over a 1 year period.

Secondary hypothesis: A pediatric-to-adult asthma transition program will improve asthma control, decrease asthma exacerbations, and reduce health care utilization in young asthma patients in the Calgary area over a 1 year period.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-04
• Study First Submitted: 2012-01-23
• Study First Submitted QC: 2012-01-25
• Study First Posted: 2012-01-30
• Primary Completion: 2014-07
• Study Completion: 2015-07
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-08
• Last Update Posted: 2016-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• clinical diagnosis of asthma (as confirmed by a pediatric respirologist or pediatrician with asthma expertise, and including evidence of variable airflow obstruction, bronchial hyperresponsiveness, airway inflammation, and/or response to therapy)

Exclusion Criteria

• patients who are known to be non-adherent within the Calgary Regional Pediatric Asthma Clinic (defined as >50% missed appointments over a 2 year period)
• patients unable to complete pulmonary function testing
• patients with a history of significant respiratory comorbid conditions (including history of cystic fibrosis, alpha-1 antitrypsin deficiency, and lung transplant - rhinosinusitis patients will not be excluded)
• patients unable to provide consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Asthma Transition Program	Asthma Transition Program	Asthma Transition Program

Primary Outcome Measures

Name	Time	Method
Asthma Quality of Life Questionnaire with Standardized Activities [AQLQ(S)]	12 months	AQLQ(S) will be recorded at baseline, 6 months, and 12 months. The primary outcome will be the change in AQLQ(S) from baseline to 12 months.

Secondary Outcome Measures

Name	Time	Method
Asthma Control Questionnaire (ACQ)	12 months	The ACQ will be administered at baseline, 6 months, and 12 months. The secondary outcome will assess change in ACQ from baseline to 12 months.

Trial Locations

Locations (1)

Calgary Regional Pediatric Asthma Clinic; 🇨🇦 Calgary, Alberta, Canada